Navigation Links
Shire Delivers Record Quarterly Revenues and Non GAAP Diluted Earnings per ADS up 42%
Date:7/18/2014

.7 2,306.1 20% 98% Royalties: FOSRENOL 22.2 19.8 12% 1% 3TC and ZEFFIX 15.8 23.8 -34% 1% ADDERALL XR 13.5 13.0 4% <1% Other 10.0 18.2 -45% <1% Total royalties 61.5 74.8 -18% 2% Other revenues 9.7 14.7 -34% <1% Total revenues 2,848.9 2,395.6 19% 100%

 

Unaudited results for the three months to June 30, 2014 

Non GAAP reconciliation 

3 months to June 30, 2014 US GAAP Adjustments Non GAAP (a) (b) (c) (d) (e) (f) $M $M $M $M $M $M $M $M Total revenues 1,502.1 - - - - - - 1,502.1 Costs and expenses: Cost of product sales 277.0 - (33.7) - - - (17.8) 225.5 R&D 236.9 (22.0) - - - - (5.8) 209.1 SG&A 496.2 (61.2) - - (2.2) (19.1) (21.1) 392.6 Gain on sale of product rights (3.8) - - 3.8 - - - - Reorganization costs 45.8 - - (45.8) - - - - Integration and acquisition costs 112.1 - (112.1) - - - - - Depreciation - - - - - - 44.7 44.7 Total operating expenses 1,164.2 (83.2) (145.8) (42.0) (2.2) (19.1) - 871.9 Operating income 337.9 83.2 145.8 42.0 2.2 19.1 - 630.2 Interest income 18.7 - - - - (18.6) - 0.1 Interest expense (11.1) - - - - - - (11.1) Other expense, net 3.3 - - - - - - 3.3 Total other income/(expense), net 10.9 - - - - (18.6) - (7.7) Income before income taxes and equity in earnings of equity method investees 348.8 83.2 145.8 42.0 2.2 0.5 - 622.5 Income taxes 176.5 (31.5) (15.3) (12.7) (0.8)(216.0) - (99.8) Equity in earnings of equity method investees, net of tax 3.0 - - - - - - 3.0 Net income from continuing operations 528.3 51.7 130.5 29.3 1.4 (215.5) - 525.7 Loss from discontinued operations, net of tax (5.2) - - 5.2 - - - - Net income 523.1 51.7 130.5 34.5 1.4 (215.5) - 525.7 Weighted average number of shares (millions) - diluted 590.3 - - - - - - 590.3 Diluted earnings per ADS 265.8c 26.5c 66.4c 17.5c 0.6c (109.5) - 267.3c

The following items are included in Adjustments:

  1. Amortization and asset impairments: Impairment of IPR&D intangible asset ($22.0 milli
    '/>"/>

SOURCE Shire plc
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc.
2. arGEN-X Receives Two Preclinical Milestone Payments Under Collaboration With Shire
3. Shire Extends Tender Offer for ViroPharma
4. Shire Reports Top-Line Results on OPUS-2, a Phase 3 Study Investigating the Use of Lifitegrast (5.0% Ophthalmic Solution) in Adults With Dry Eye Disease
5. MinuteClinic Opens First Clinic Locations in New Hampshire
6. Block & Leviton LLP Investigates ViroPharma Inc. for Possible Breaches of Fiduciary Duty in Connection with Its Acquisition by Shire PLC.
7. Shire to Present at the Bank of America Merrill Lynch Global Health Care Conference
8. Shire to Present at the Morgan Stanley Global Healthcare Conference
9. Shire Reports 7% Product Sales Growth: Anticipating Double Digit Non GAAP Earnings Growth in 2013
10. Shire Announces Award Recipients for 2013 US ADHD Scholarship Program
11. Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)...  GSI Group Inc. (NASDAQ: GSIG ) (the "Company", ... precision motion, and vision technologies to original equipment manufacturers in ... for the second quarter of 2015.Financial HighlightsThree Months Ended(In millions, ... , $ , 96.5 $ ... $ , 10.3 $ , ...
(Date:8/5/2015)... 2015  Innovative therapies that transform quickly progressing, ... – into manageable, chronic conditions offer great hope ... however, they present pharmaceutical companies with unusual drug ... and marketing decisions based on a patient population ... new methods of collecting and analyzing complex clinical, ...
(Date:8/5/2015)... WESTLAKE VILLAGE, Calif. , Aug. 5, ... and KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH ) today ... agreement with respect to Allergan,s pending acquisition of KYTHERA ... agreement amends and restates the original merger agreement entered ... amended on July 1, 2015. Logo - ...
Breaking Medicine Technology:GSI Group Announces Financial Results for the Second Quarter of 2015 2GSI Group Announces Financial Results for the Second Quarter of 2015 3GSI Group Announces Financial Results for the Second Quarter of 2015 4GSI Group Announces Financial Results for the Second Quarter of 2015 5GSI Group Announces Financial Results for the Second Quarter of 2015 6GSI Group Announces Financial Results for the Second Quarter of 2015 7GSI Group Announces Financial Results for the Second Quarter of 2015 8GSI Group Announces Financial Results for the Second Quarter of 2015 9GSI Group Announces Financial Results for the Second Quarter of 2015 10GSI Group Announces Financial Results for the Second Quarter of 2015 11GSI Group Announces Financial Results for the Second Quarter of 2015 12GSI Group Announces Financial Results for the Second Quarter of 2015 13GSI Group Announces Financial Results for the Second Quarter of 2015 14GSI Group Announces Financial Results for the Second Quarter of 2015 15GSI Group Announces Financial Results for the Second Quarter of 2015 16GSI Group Announces Financial Results for the Second Quarter of 2015 17GSI Group Announces Financial Results for the Second Quarter of 2015 18GSI Group Announces Financial Results for the Second Quarter of 2015 19GSI Group Announces Financial Results for the Second Quarter of 2015 20GSI Group Announces Financial Results for the Second Quarter of 2015 21GSI Group Announces Financial Results for the Second Quarter of 2015 22GSI Group Announces Financial Results for the Second Quarter of 2015 23GSI Group Announces Financial Results for the Second Quarter of 2015 24GSI Group Announces Financial Results for the Second Quarter of 2015 25GSI Group Announces Financial Results for the Second Quarter of 2015 26New analytics improve pharmaco strategic decision-making for some deadly diseases 2New analytics improve pharmaco strategic decision-making for some deadly diseases 3Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration 2Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration 3Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration 4Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration 5Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration 6Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration 7Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration 8
... ORLANDO, Florida and MELBOURNE, Australia, November 14, 2011 ... Mesenchymal Precursor Cell (MPC) product for cardiovascular diseases, was safe ... responses to donor cells , , ... events (MACE) in patients with congestive heart failure over a ...
... Fla., Nov. 14, 2011 Patients ... stroke and blood clots, failed to remain on the treatment ... according to a study presented at the American Heart Association,s ... The research conducted by Medco Research Institute™, a subsidiary ...
Cached Medicine Technology:Positive Results from Phase 2 Trial of Mesoblast's Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting 2Positive Results from Phase 2 Trial of Mesoblast's Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting 3Positive Results from Phase 2 Trial of Mesoblast's Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting 4Medco Research Institute Study Shows Some Patients Discontinue New Anticoagulant Drug Early, Which May Increase Stroke Risk 2Medco Research Institute Study Shows Some Patients Discontinue New Anticoagulant Drug Early, Which May Increase Stroke Risk 3Medco Research Institute Study Shows Some Patients Discontinue New Anticoagulant Drug Early, Which May Increase Stroke Risk 4
(Date:8/5/2015)... ... August 05, 2015 , ... Optimized Care Network (OCN) will join providers ... provide more patient choice during the first-ever Convenient Healthcare and Pharmacy Collaborative, Aug. 6-7. ... the challenges confronting retail clinics, how to expand their role and future trends in ...
(Date:8/5/2015)... ... August 05, 2015 , ... Gorilla Grow Tent , ... tent for those with height restrictions. Gorilla Grow Tent has achieved incredible popularity ... tent construction, attention to detail and overall superiority in the indoor grow tent/indoor ...
(Date:8/5/2015)... , ... August 05, 2015 , ... ... Services, LLC (“Frugal Financial”), a wholly-owned subsidiary. Frugal Financial is a registered investment ... mission to complement and extend Employee Fiduciary’s core values and services , ...
(Date:8/5/2015)... ... August 05, 2015 , ... The ceramic membrane market ... a firm annualized growth of 11.7% between 2015 and 2020. Asia-Pacific region, being ... increasing demand of ceramic membranes technologies and effective filtration & separation processes. The ...
(Date:8/5/2015)... ... August 05, 2015 , ... Friendly Smiles Dental Care, ... Dr. Daniel H. Huynh, DMD and Dr. Michael J. Foley, DMD. The full service ... at all three location in the Tampa Bay area, where Friendly Smiles Dental Care ...
Breaking Medicine News(10 mins):Health News:Optimized Care Network Joins First-ever Convenient Healthcare and Pharmacy Collaborative 2Health News:Optimized Care Network Joins First-ever Convenient Healthcare and Pharmacy Collaborative 3Health News:Best Grow Tent and Indoor Greenhouse Brand Gorilla Grow Tent Launches New Shorty Line 2Health News:Employee Fiduciary Announces Subsidiary 2Health News:Ceramic Membrane Market to Grow at a CAGR of 11.7% to 2020 2Health News:Ceramic Membrane Market to Grow at a CAGR of 11.7% to 2020 3Health News:Ceramic Membrane Market to Grow at a CAGR of 11.7% to 2020 4Health News:Ceramic Membrane Market to Grow at a CAGR of 11.7% to 2020 5Health News:Friendly Smiles Dental Care Welcomes New Doctors 2
... discharge tied to more readmissions, at-home deaths, study finds ... for heart failure are being discharged faster, but the ... new study finds. , While in-hospital death rates have ... could say that they are worse off," said Dr. ...
... a role to play in disease detection , TUESDAY, June ... sniff out signs of prostate cancer in human urine, adding ... man,s best friend. , Some scientists have questioned similar reports ... but the lead author of this latest study said the ...
... Early trials using targeted monoclonal antibodies in combination with ... metastatic breast cancer, according to research that will be ... Cancer Center at the 2010 meeting of the American ... study uses an antibody to enhance the effectiveness of ...
... ... wide reach of the tobacco industry and its influence on young people, military veterans and national ... (Vocus) June 1, ... and its influence on young people, military veterans and national health care reform. , , ,The ...
... expert suggests , TUESDAY, June 1 (HealthDay News) -- New ... monitoring patients who appear to have low-risk forms of prostate ... debate in recent years over whether doctors are treating prostate ... use "watchful waiting" to monitor patients to see if signs ...
... available in French . Two McGill researchers, ... for their exceptional contributions to science from the Natural Sciences ... Honourable Gary Goodyear, Minister of State (Science and Technology), and ... Research Council of Canada (NSERC), announced the winners of the ...
Cached Medicine News:Health News:Shorter Hospital Stays May Hinder Heart Failure Patients 2Health News:Shorter Hospital Stays May Hinder Heart Failure Patients 3Health News:Dog Sniffs Out Prostate Cancer in Small Study 2Health News:Targeted immunotherapy shows promise for metastatic breast, pancreatic cancers 2Health News:Targeted immunotherapy shows promise for metastatic breast, pancreatic cancers 3Health News:Targeted immunotherapy shows promise for metastatic breast, pancreatic cancers 4Health News:UCSF Analyses Detail Tobacco Industry Influence on Health Policy 2Health News:UCSF Analyses Detail Tobacco Industry Influence on Health Policy 3Health News:UCSF Analyses Detail Tobacco Industry Influence on Health Policy 4Health News:Value of Monitoring Low-Risk Prostate Cancer Assessed 2
... the pioneers of surgical lighting, including ... automatic reserve bulb, an integrated surgical ... sets the standard for advanced lighting ... our latest generation surgical light ...
... SimpliCT® is an interventional guidance device ... significantly improve the accuracy of computed ... to improving accuracy, SimpliCT® also has ... of CT-guided puncture procedures including biopsies ...
Flat tip, bare fiber, no cooling, polished SMA 905, 3 meters long. Sold in boxes of five. Each part is individually packaged in sterile Tyvek bags....
Get YAG laser performance from your diode laser. Our proprietary NA shift technology offers efficient coupling of low divergence fiber to high divergence lasers...
Medicine Products: